Appointment to the Clinical Advisory Board

RNS Number : 0726G
Surgical Innovations Group PLC
03 June 2013




Surgical Innovations Group plc

("SI" or the "Company")


Appointment to the Clinical Advisory Board


Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of creative solutions for minimally invasive surgery ('MIS'), announces the appointment of Consultant Paediatric Urologist surgeon Henrik Steinbrecher to its Clinical Advisory Board ('CAB') with immediate effect.


Henrik Steinbrecher, BSc, MB.BS, FRCS, MS, FRCS (Paeds), will be the first Consultant Paediatric Urologist to join the UK CAB at SI. Henrik previously worked as a Consultant in Paediatric Urology specialising in Paediatric Surgery and Minimally Invasive Surgery at Southampton Hospital NHS Trust. Henrik is currently a consultant at Southampton University Hospital NHS Trust where he has been a consultant since 1998. Henrik has been an executive member of the Royal College of Paediatrics ('RCPCH') Clinical Directors Group from April 2004-June 2006, has been an advisor on Simulation Training for Specialist Advisory Committee ('SAC') in Paediatric Surgery, was a founding member of the British Association of Paediatric Endoscopic Surgeons in 1999 and President of this Association in 2010-2012. He was also a founding member of The European Society of Paediatric Endoscopic Surgeons in 2009-2010.


SI's focus is to expand into the paediatric market this coming year with an advanced range of innovative 3mm laparoscopic devices for 'Ultra' MIS, which can be used in all areas of general surgery, especially MIS in children. Having Henrik on the CAB will help SI's strategy in further development of their innovative products.


Graham Bowland, Chief Executive Officer for Surgical Innovations, said: "We are delighted to welcome Henrik to the CAB, his expertise in Paediatric surgery will help SI focus in this specialist area. The CAB now includes key opinion leaders from different specialties of MIS and ensures that we remain at the forefront of MIS product development."

- ENDS -




Surgical Innovations Group plc

Doug Liversidge, Non-Executive Chairman

Tel: +44 (0) 113 230 7597

Graham Bowland, Chief Executive Officer



Panmure Gordon (Nominated Advisor & Broker)

Freddy Crossley / Fred Walsh (Corporate Finance)

Tel: +44 (0) 20 7886 2500

Adam Pollock/ Victoria Boxall (Corporate Broking)




Walbrook PR Ltd

Tel: +44 (0) 20 7933 8780

Paul McManus

Mob: 07980 541 893 or

Lianne Cawthorne

Mob: 07584 391 303 or


Notes to Editors:


About Surgical Innovations Group plc


Surgical Innovations Group plc specialises in the design and manufacture of creative solutions for minimally invasive surgery (MIS) and industrial markets. 


As well as manufacturing single-use and reusable instruments for the laparoscopic market, the Group has pioneered its flagship Resposable® instrumentation combining both single use and reusable components, ensuring ongoing revenue streams and delivering the optimum procedure performance to cost ratio.


Over 100 people are employed at the Group's 32,000 square feet facility in Leeds, with in-house design, plastic injection moulding and manufacturing equipment, producing products to the highest quality standards.


The Group's patented products are sold through three main channels:


SI brand

Through an established network of distribution partners, Surgical Innovations branded products are sold in major medical markets including North America, Britain, South East Asia, Australasia and the Indian subcontinent. 


OEM and IP

The Group supplies large medical device companies on an OEM basis, generating both sales and IP royalty fees.  Clients include Teleflex Medical, Olympus and CareFusion. 




SI's patented segment technology has been applied to the industrial market enabling customers to undertake inspection and maintenance of large-scale equipment, in situ with minimum disassembly and downtime. 


For more information, see


This information is provided by RNS
The company news service from the London Stock Exchange
UK 100

Latest directors dealings